A Randomized Controlled Trial of Rivaroxaban for the Prevention of Major Cardiovascular Events in Patients With Coronary or Peripheral Artery Disease (COMPASS - Cardiovascular OutcoMes for People Using Anticoagulation StrategieS).
A Randomized Controlled Trial of Rivaroxaban for the Prevention of Major Cardiovascular Events in Patients With Coronary or Peripheral Artery Disease (COMPASS - Cardiovascular OutcoMes for People Using Anticoagulation StrategieS).
The primary objectives of this study are:
Inclusion Criteria:
- Meet criteria for CAD and/or PAD
Subjects with CAD must also meet at least one of the following criteria:
Exclusion Criteria:
Ciudad Autón. de Buenos Aires, Ciudad Auton. de Buenos Aires C1425AGC, Argentina
Ciudad Auton. de Buenos Aires, C1023AAB, Argentina
Ciudad Auton. de Buenos Aires, C1181ACL, Argentina
Ciudad Auton. de Buenos Aires, C1405BUB, Argentina
Bruxelles - Brussel, 1070, Belgium
Ontario, P3E 5M4, Canada
Valdivia, Los Lagos Region, Chile
Wudan, Hubei 430022, China
Forlì Cesena, Emilia-Romagna 47100, Italy
Miyako-gun, Fukuoka 800-0344, Japan
Onga-gun, Fukuoka 811-4342, Japan
Miura-gun, Kanagawa 240-0116, Japan
Bunkyo-ku, Tokyo 113-8431, Japan
Itabashi-ku, Tokyo 173-8610, Japan
Batu Caves, Selangor, 68100, Malaysia
Kedah, 05460, Malaysia
Sungai Buloh Selangor, 47000, Malaysia
Metro Manila, 1502, Philippines
Pinelands, Eastern Cape 7503, South Africa
Londonderry Co. Londonderry, Derry BT47 6SB, United Kingdom
West Bromich, West Midlands B71 4HJ, United Kingdom